Comparison between sodium cromoglycate (MDI: metered‐dose inhaler) and beclomethasone dipropionate (MDI) in treatment of adult patients with mild to moderate bronchial asthma A double‐blind, double‐dummy randomized, parallel‐group study
Authors:
Abstract
This study compared the efficacy and tolerability of sodium cromoglycate (SC) and beclomethasone dipropionate (BDP) in adult patients with bronchial asthma inadequately treated with bronchodilators alone. The study was a double‐blind, randomized, double‐dummy, parallel‐group study. Patients with mild to moderate symptomatic asthma, inadequately treated with bronchodilators only, were, after a 2–week run‐in (base‐line) period, randomized to 8 weeks of treatment with either SC 10 mg four times daily or BDP 100 μg four times daily. Salbutamol metered‐dose inhaler was given as relief medication. A total of 37 patients were randomized for treatment, 19 patients in the SC group and 18 patients in the BD group. Efficacy and safety were determined by daily record card data: morning and evening peak‐expiratory‐flow rates (PEER), daytime and nighttime asthma symptom scores, and rescue salbutamol use. At clinic visits, FEV1 and FVC were measured, as were the physician's and the patient's assessment of the medication at the end of the study. The safety and tolerability of the trial medication were assessed by monitoring adverse events throughout the study. A clinically and statistically significant improvement of the asthma in FEV1, symptom scores, rescue medication, and global opinion of efficacy was observed, and both groups provided equivalent efficacy. The morning PEFR as well as the evening PEFR for both groups improved, but was statistically significant only for the BDP group (M‐PEFR). Both drugs were well tolerated with only a few minor adverse events. This trial shows that SC and BDP are equally effective anti‐inflammatory treatments for mild to moderate bronchial asthma in adults.Keywords
This publication has 12 references indexed in Scilit:
- Purpura and dermal thinning associated with high dose inhaled corticosteroids.BMJ, 1990
- A New Approach to the Treatment of AsthmaNew England Journal of Medicine, 1989
- Comparison of 1 mg and 5 mg sodium cromoglycate metered dose inhalers in the treatment of asthma: A 12-week double-blind, parallel group trialCurrent Medical Research and Opinion, 1989
- A comparison of the effects of sedium cromoglycate and beclomethesone dipropionate on pulmonary function and bronchial hyperreactivity in subjects with asthmaJournal of Allergy and Clinical Immunology, 1987
- Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamineJournal of Allergy and Clinical Immunology, 1987
- Studies on Histamine Metabolism in Allergen‐Induced AsthmaAllergy, 1980
- The combined use of betamethasone valerate and sodium cromoglycate in the treatment of asthmaClinical & Experimental Allergy, 1977
- Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination.BMJ, 1976
- Betamethasone 17 valerate aerosol and disodium cromoglygate in severe childhood asthmaRespiratory Medicine, 1975
- Lipomatous pseudohypertrophy of the pancreas associated with chronic pulmonary suppuration in an adultPostgraduate Medical Journal, 1974